Skip to main content
Premium Trial:

Request an Annual Quote

CRISPR-Based Ifegenia Tool Could Be Used to Control Malaria-Carrying Mosquito Populations

A CRISPR-based tool could be used to disrupt a key gene found among female Anopheles gambiae mosquitos, which can carry and transmit malaria, according to a new study in Science Advances. Researchers from the University of California, San Diego, developed a binary CRISPR-based vector control tool they've dubbed Ifegenia — for 'inherited female elimination by genetically encoded nucleases to interrupt alleles' — that disrupts the femaleless (fle) gene needed for the development of female Ae. gambiae. This disruption leads to the death of female mosquitos during the larval stage but does not affect male mosquitos. Because of this, the researchers say Ifegenia could be used to identify female and male mosquitos as well as to control the mosquito population. Their modeling further suggests that iterative releases of non-biting male mosquitos harboring Ifegenia would lead to long-term and controllable population suppression. "In all, Ifegenia not only provides important insights on the function of fle and demonstrates its value as a gene of interest for the vector control field at large but also provides a [genetic sexing system] and the first tool of its kind to combat malaria transmission in A. gambiae," the researchers write.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.